No abstract available
MeSH terms
-
Adolescent
-
Adult
-
Alphapapillomavirus / immunology
-
Alphapapillomavirus / pathogenicity
-
Child
-
Developing Countries
-
Dose-Response Relationship, Immunologic
-
Female
-
Health Policy*
-
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
-
Humans
-
Immunization Schedule
-
Mexico
-
Papillomavirus Infections / epidemiology
-
Papillomavirus Infections / prevention & control
-
Papillomavirus Infections / virology
-
Papillomavirus Vaccines* / administration & dosage
-
Papillomavirus Vaccines* / immunology
-
Uterine Cervical Neoplasms / epidemiology
-
Uterine Cervical Neoplasms / prevention & control
-
Uterine Cervical Neoplasms / virology
-
Vaccination* / legislation & jurisprudence
-
Young Adult
Substances
-
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
-
Papillomavirus Vaccines
-
human papillomavirus vaccine, L1 type 16, 18